"we are glad our concerns have been addressed by the coroner's office but the western trust has a lot to answer for..
.fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.
.
. ..
.
.
."we are glad our concerns have been addressed by the coroner's office but the western trust has a lot to answer for..
.
.